Does caffeine therapy improve cognitive impairments in valproic acid rat model of autism
محل انتشار: هشتمین کنگره علوم اعصاب و پایه و بالینی
سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 456
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
NSCMED08_551
تاریخ نمایه سازی: 15 دی 1398
چکیده مقاله:
Background and Aim : Autism spectrum condition is a neurodevelopmental disorder. Pregnant rats’ exposure to valproic Acid (VPA) causes cognitive deficits in pups similar to those observed in humans with autism- like behaviors. Caffeine therapy is an important pharmacological research line for studying the involvement of adenosine receptors in cognitive functions. Here, we investigate the effects of caffeine on cognitive, anxiety-like behaviors and social functions of offspring’s rats following congenital VPA administration using by Morris water maze (MWM), Elevated plus maze, and three chamber social assay, respectively.Methods : On postnatal day 21, male rats received caffeine orally in drinking water at a dose of 1mg/mL for 30 days. The pups were divided into four groups as follows: (1) vehicle (treated by saline), (2) VPA group, (3) Caffeine group and (4) VPAþCaffeineResults : We observed remarkable learning and memory impairments, increased anxiety like behaviors and social interaction deficits which were observed in autism rats can improve after caffeine therapy.Conclusion : our results suggest that VPA could disrupt some aspects of cognitive, social and anxiety- like behaviors but chronic administration of Caffeine may partly restore these behaviors close to vehicle treated animals in this rat model.
کلیدواژه ها:
نویسندگان
Farahnaz Taheri
Neuroscience Research Center, Institute of neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
Khadijeh Esmaeilpour
Neuroscience Research Center, Institute of neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
Mohammad Amin Rajizadeh
Neuroscience Research Center, Institute of neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran